Active	Status	Sponsor type	Region	Phase	Filter
5 Active 1 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rivera, Jose Arturo Rodriguez
MODEL, NCT05516992: Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine	Active, not recruiting	3	417	US	SB-01 For Injection, Sham Needle	Spine BioPharma, Inc, MCRA	Lumbar Degenerative Disc Disease	02/25	08/25
ARGON-2, NCT04378010 / 2019-003876-38: A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH	Terminated	2b	98	Europe, Canada, US, RoW	EDP-305 1.5 mg, EDP-305, EDP-305 2 mg, Placebo	Enanta Pharmaceuticals, Inc, Enanta Pharmaceuticals, Inc.	Non-Alcoholic Steatohepatitis	10/21	11/21
NCT04042844: A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)	Recruiting	2	99	US	BRTX-100, Saline	BioRestorative Therapies	Lumbar Disc Disease	08/24	08/25
BOCADOS-IC, NCT05923138: Nutritional Approach in Adults Followed up in Spanish Hospitals for Heart Failure	Recruiting	N/A	264	Europe	MULTIDOMAIN NUTRITIONAL INTERVENTION: DIET, EXERCISE AND NUTRITIONAL SUPPLEMENTS, NUTRITION TEAM, CONTROL	Spanish Society of Cardiology	Heart Failure	09/24	12/24
NCT06419855: Study to Evaluate the Effectivity and Safety of BIOSCAFF®H Compared to DuraGen®, in Patients Undergoing Dural Repair	Terminated	N/A	2	RoW	Human collagen matrix graft, Bovine collagen matrix graft	Top Health S.A.P.I DE C.V., CLINICAL RESEARCH PS MEXICO	Cerebrospinal Fluid Leakage	02/25	02/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rivera, Jose Arturo Rodriguez
MODEL, NCT05516992: Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine	Active, not recruiting	3	417	US	SB-01 For Injection, Sham Needle	Spine BioPharma, Inc, MCRA	Lumbar Degenerative Disc Disease	02/25	08/25
ARGON-2, NCT04378010 / 2019-003876-38: A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH	Terminated	2b	98	Europe, Canada, US, RoW	EDP-305 1.5 mg, EDP-305, EDP-305 2 mg, Placebo	Enanta Pharmaceuticals, Inc, Enanta Pharmaceuticals, Inc.	Non-Alcoholic Steatohepatitis	10/21	11/21
NCT04042844: A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)	Recruiting	2	99	US	BRTX-100, Saline	BioRestorative Therapies	Lumbar Disc Disease	08/24	08/25
BOCADOS-IC, NCT05923138: Nutritional Approach in Adults Followed up in Spanish Hospitals for Heart Failure	Recruiting	N/A	264	Europe	MULTIDOMAIN NUTRITIONAL INTERVENTION: DIET, EXERCISE AND NUTRITIONAL SUPPLEMENTS, NUTRITION TEAM, CONTROL	Spanish Society of Cardiology	Heart Failure	09/24	12/24
NCT06419855: Study to Evaluate the Effectivity and Safety of BIOSCAFF®H Compared to DuraGen®, in Patients Undergoing Dural Repair	Terminated	N/A	2	RoW	Human collagen matrix graft, Bovine collagen matrix graft	Top Health S.A.P.I DE C.V., CLINICAL RESEARCH PS MEXICO	Cerebrospinal Fluid Leakage	02/25	02/25